FEATURES | NUMBER (N) | PERCENTAGES (%) |
Number of patients | 21 | 100 |
Number of GIAs | 21 | 100 |
Gender |
|
|
Male | 5 | 23.80 |
Female | 16 | 76.20 |
Male: female ratio | 1:3.2 |
|
AGE (years) |
|
|
Mean (range) | 46 (21 - 68) |
|
Mode of revelation |
|
|
Mass effect | 13 | 61.90 |
CN deficits | 06 | 28.57 |
Headaches | 04 | 19.04 |
Intracranial hypertension | 03 | 14.28 |
Seizures | 03 | 14.28 |
Incidental | 03 | 14.28 |
SAH; Ischemic stroke (each) | 01 | 04.76 |
Clinical manifestations |
|
|
Headaches | 12 | 57.14 |
CN deficits | 09 | 42.85 |
SAH | 03 | 14.28 |
Seizures | 03 | 14.28 |
Diplopia | 02 | 09.52 |
Motor or sensitive deficit (each) | 01 | 04.76 |
Aneurysm features |
|
|
Mean size (range) | 33.75 mm (26 - 42) | ------ |
Carotid-ophthalmic | 07 | 33.33 |
Cavernous sinus | 04 | 19.04 |
MCA | 05 | 23.80 |
Multiloculated | 07 | 33.33 |
Fusiform* | 05 | 23.80 |
Saccular | 05 | 23.80 |
Multiple | 03 | 14.28 |
Circle of Willis anomalies§ | 13 | 61.90 |
Past medical history |
|
|
Smoking | 08 | 38.09 |
Arterial hypertension | 03 | 14.28 |
Migraine headaches | 02 | 09.52 |
Family history of cerebral aneurysm | 01 | 04.76 |
Delay between STA-MCA bypass & PAO (days) | 14 (6 - 30) |
|
Follow up (months) |
|
|
Mean (range) | 30 (6 - 72.5) |
|